Summary In this work, we investigated the autonomous proliferation, bcl-2 expression and number of apoptotic cells in the bone marrow of patients with confirmed diagnosis of myelodysplastic syndromes (MDS). Normal bone marrow cells obtained from donors of the Clinical Hospital of this university were used as a control. The autonomous proliferation, evaluated by lonal culture without exogenous growth factor, and the number of apoptotic cells in bone marrow kept for 10 days in liquid cultures at 3TC and 5% carbon dioxide, were significantly greater in MDS patients than in control subjects (P = 0.001, Wilcoxon). However, bcl-2 expression, measured by immunocytochemistry, was significantly lower in MDS patients than in normal individuals (P = 0.002, Wilcoxon). These results suggest that the high proliferation activity in MDS patients may be counteracted by the high level of medullar cell death, which might be related to the lower bcl-2 expression.
Myelodysplastic syndromes (MDS) consist of a group of acquired haemopoietic disorders with evidence of trilineage dysplasia and an incidence of 30% of eventual transformation into acute myeloid leukaemia (AML) (Ganser and Hoelzer. 1992 : Loffler et al. 1992 : Willemze et al. 1993 ). An apparent paradox in MDS is that patients with these disorders have peripheral cytopenias. despite frequently having normo-or hypercellular bone marrow (Raza et al. 1995) . These contradictory findings may be explained by an excessive intramedullary cell death in the face of normal or even enhanced rates of proliferation. Recently. some studies have suggested that the increased programmed cell death. or apoptosis. may cancel the normal or high proliferation activity in MDS patients (Raza et al. 1995) . One reason for this increased number of apoptotic cells may be transcriptionally deregulated bcl-2 expression. bcl-2 was initially detected at a translocation breakpoint in B-cell follicular lymphomas and was subsequently shown to have a role in preventing apoptosis (Korsmeyer. 1992 : Vaux. 1993 ). The protein is found in various fetal tissues destined for long-term survival and in adult tissues in which apoptosis has an important homeostatic role (Hockenbery et al. 1991) . bcl-2 is expressed in the myeloid lineage at the myeloblastic and promyelocytic stages of differentiation. diminishing with the maturation of cells into granulocytes (Delia et al. 1992) . Furthermore. the early cell death observed in bone marrow cells of MDS patients suggests abnormalities in the cell cycle control pathways. which can also affect cellular proliferation. For example. suppression of the apoptotic-enhancing effect of deregulated c-mvc by either bcl-2 or mutated p53 allows expression of an unopposed proliferate signal (Vaux et al. 1988 : Green et al. 1994 . Moreover. the association between proliferation activity. bc1-2 expression and apoptosis has not been previously determined. In the present work. we examined bcl-2 expression. autonomous colony formation (without exogenous growth factors) and apoptosis in bone marrow cells from MDS patients with the aim of identifying the process involved in the ineffective haemopoiesis observed in this clonal disorder.
MATERIAL AND METHODS Cases
bc1-2 expression was evaluated in all the patients (n = 15).
Autonomous colony formation (CFU-C) and apoptosis were studied in 12 and 11 patients respectively. The MDS patients were defied according to the FAB cooperative group (Bennett et al. 1982) . Bone marrow cells from 19 blood donors of the Clinical Hospital in this universitv were used as control subjects (n = 11 for apoptosis. n = 15 for bcl-2 expression and n = 19 for autonomous proliferation). All subjects gave informed consent and the study was approved by the ethics committee of this hospital. A maximum of 3 ml of bone marrow was allowed to be used for this study.
Bone marrow cell separation Mononuclear cells were separated from 3 ml of heparinized bone marrow by 30 mm centrifutation at 400g in Ficoll-Hypaque (density 1.077g ml-l: Pharmacia Fine Chemicals. Uppsala. Sweden).
The cells from the interface were washed three times with RPMI-1640 (Sigma. St Louis. MO. USA) and counted for autonomous colony formation culture. bc1-2 expression and apoptosis.
Assay for autonomous colony formation (CFU) Assay with mononuclear cell suspensions was performed in 2 ml of agar cultures in 35-mm Petri dishes using 5 x l0W cells ml. The medium used was Iscove's modified Dulbecco medium (Sigma) containing 20% fetal calf serum (Sigma) and 0.6% agar. Colony formation was studied without addition of any exogenous growth factors. The plates were incubated at 370C in 5% carbon dioxide in air at 100% humidity. Colonies were counted after 14 days at 35 x magnification using a dissection microscope (Metcalf, 1984 (Maung et al, 1994) . The percentage of positive bcl-2 mononuclear cells present in MDS patients and in control subjects was calculated after counting at least 300 cells.
Apoptotc cells
Viability of mononuclear cells isolated from heparinized bone marrow was determined by the trypan blue dye exclusion test. The cells were resuspended in 20% serum/RPMI-1640 medium (Gibco-USA) supplemented with 2 mm 1-' glutamnine, 100 U ml-' penicillin and 100 gg mll streptomycin. The cells were seeded at a density of 5 x 101 cells ml-l and incubated in an atmosphere of 95% air/5% carbon dioxide at 370C for 10 days. Cytocentrifuge preparations from MDS bone marrow cells kept for 10 days in culture were performed. The slides were then stained with haematoxylin and the apoptotic cells were determined under high power Brtihs Joukmal of Cancer (1998) (1997) as follows: overall shrinkage and homogeneously dark basophilic nuclei: presence of nuclear fragments (apoptotic bodies); sharply delineated cell borders surrounded by empty space: homogeneous eosinophilic cytoplasm. The percentage of apoptotic cells was calculated after counting at least 300 cells.
Statisticals analysis
Statistical comparison of the results from MDS patients and control subjects was performed using the Wilcoxon test. A result of P < 0.05 was considered statistically significant.
RESULTS
The growth and differentiation of early bone marrow progenitor cells (CFU/5 x 10' cells ml-') in the absence of any exogenous growth factors, in patients with a confirmed diagnosis of myelodysplastic syndrome (MDS) were significantly higher than in control subjects (P = 0.001. Wilcoxon, Figure 1) . Out of 12 patients. only two presented values similar to that of control subjects. The percentage of positive mononuclear bc1-2 cells was reduced in MDS patients in relation to normal individuals (P = 0.002. Wllcoxon, Figure 2 ). However, the percentage of apoptotic cells was significantly increased in MDS bone marrow cells in relation to the percentage in control subjects (P = 0.001, Wilcoxon, Figure 3 ). We did not observe a correlation between bcl-2 expression. autonomous proliferation and FAB classification. It was not possible to perform the correlation between bcl-2 expression and apoptosis as almost all cells were in an advanced stage of apoptosis by the tenth day of culture (Figure 3 ).
DISCUSSION
Myelodysplastic syndromes (MDS) are clonal disorders of pluripotent haematopoietic stem cells, generally of unknown aetiology. occurring predominantly in the elderly, characterized by ineffective haematopoiesis leading to blood cytopenias despite of the presence of a hypercellular or normocellular bone marrow (Fenaux. 1996) . Recently. some studies have suggested that an important factor involved in the peripheral cytopenias in MDS patients is an increase in programmed cell death (apoptosis). In this regard, a high range of apoptosis was observed in this study when the MDS cells were cultivated in liquid cultures and evaluated morphologically. These results corroborate the findings reported by Raza et al (1995) . who observed more than 75% of apoptosis in stromal bone marrow cells of the MDS patients using the in situ end-labelling technique (ISEL). These findings are complementary as the ISEL technique allows the study of apoptosis at the very early stages after initial changes in DNA levels, whereas our morphological approach reveals the late stages of apoptosis. Therefore. based on these results and other reports (Clark and Lampert. 1990 : Yoshida, 1993 : Raza et al. 1995 : Yoshida et al. 1995 : Bogdanovic et al. 1997 ). we suggest that apoptosis is a mechanism responsible. at least in part. for the ineffective haematopoiesis in MDS.
Alterations in the bc1-2 expression are involved in the regulation of apoptosis (Gajewaki and Thompson. 1996: Kroemer. 1997 ). as well as in the sensitivity of cells to a variety of cytotoxic drugs (Kamesaki et al. 1993) . In this regard. we observed a low bcl-2 expression in mononuclear MDS cells, suggesting that this protooncogene may be involved in the high rate of cell death observed O Cancer Research Camnpaign 1998 bcl-2 expression in MDS 623 in this study. These findings suggest impairment in the pathways involved in proliferation. differentiation and cell death. In this field. we observed autonomous colony formation in the absence of any exogenous haemopoietic growth factors in MDS patients. These results support the hypothesis. in the literature. that early cell death cancels high or normal proliferation activity (Raza et al. 1995) . Autonomous proliferation activity seems to be related to the autocrine production of some growth factors in acute myeloid leukaemia (AML) : Bradbury et al. 1994 : Bradbury and Russell: 1995 . Russel et al. 1995 : Hu et al. 1996 . However. Shetty et al (1996) . reported a relative absence or undetectable levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) in MDS patients. which denotes another mechanism involved in the progression of this disease. In this regard. Soligo et al (1996) . observed an overexpression of GM-CSF and ckit receptors in MDS patients. suggesting an increased sensitivity of bone marrow progenitors. leading to an autonomous colony formation without exogenous growth factors. On the other hand. patients with MDS have normal or elevated levels of erythropoietin (Epo) (Jacobs et al. 1989 ) and activation of StatS by Epo is impaired in these patients (Hoefsloot et al. 1997) . Moreover. alterations in genes that control the proliferation activity and cell death can be involved in the autonomous colony formation observed in our study. such as the c-mvc oncogene (Nowak. 1992 . Rajapaksa et al. 1996 or a high p21 ras expression (Silva et al. 1997) Another factor that could help to explain our results is the recent finding in our laboratory (unpublished data) showing a high p53 expression in MDS patients. The p53 overexpression might be associated with bcl-2 mRNA and protein reduction. probably because the 5' untranslated region of the bcl-2 gene contains a p53-negative responsive element, through which p53 may directly or indirectly transcriptionally down-regulate the expression of bcl-2 (Haldar et al. 1994 : Miyashita et al. 1994 : Lepelley et al. 1995 . Furthermore. p53 stimulates the expression of bar. a gene that encodes a dominant inhibitor of the bcl-2 protein (Miyashita et al. 1994) .
Although these results suggest a participation of bcl-2 expression in the high rate of cell death in MDS patients. further investigations are necessary to clarify the molecular mechanisms involved in the progress of this disease. It has been demonstrated that the cell-surface receptor FAS/APO-I (CD95) is able to trigger apoptosis in a variety of cell types (Karawajew et al. 1997 ).
However. in relation to the FAS expression on MDS cells. Munker et al (1996) . described in 17 MDS patients that the average value of soluble CD95 was not statistically different from normal control subjects and no correlation was found with the FAB type.
In conclusion. the MDS cells with a higher baseline level of growth stimulation may contribute to additional mutations and progression of MDS to AML. Finally. autonomous proliferation activity might be a good marker for myelodysplastic syndrome diagnosis.
